Boston Scientific (NYSE:BSX) touted data from a Phase 3 clinical trial of its TheraSphere Y-90 glass microspheres treatment.
In the trial, the TheraSphere treatment successfully met...
Cala Health, a bioelectronic medicine company developing wearable therapies for chronic disease, announces two validating moments for the non-invasive prescription therapy for essential tremor...
OssDsign AB (publ) today announced that the first patient has been included in the company’s clinical study TOP FUSION to investigate the long-term safety...
Centinel Spine has announced findings of a new study that it says strongly support the long-term safety and effectiveness of its prodisc L total disc replacement...
The trial assessed patients implanted with Micra VR TPS and with traditional TV-VVI pacemakers.
Medtronic has announced new data from the Micra Coverage with Evidence...
Supporting the Most Robust, Diverse and Longest-Term Body of Clinical Evidence for Any MIGS Technology
Multiple 5-, 6-, 7- and 8-Year Real-World Studies Published, Demonstrating...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, based on its patented biophotonic technology, announced today it had passed...
